Skip to main content
Erschienen in: European Radiology 3/2012

01.03.2012 | Magnetic Resonance

Utility of diffusion-weighted imaging in the evaluation of liver fibrosis

verfasst von: Ayse Ahsen Bakan, Ercan Inci, Selim Bakan, Suut Gokturk, Tan Cimilli

Erschienen in: European Radiology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the usefulness of diffusion- weighted MRI (DWI) in the detection and staging of liver fibrosis and inflammation.

Methods

DWI was performed with b-factors of 0, 500 and 1000 s/mm². ADC values were obtained by placing circular regions of interest in four segments of the liver. Differences between the study (n = 34) and control groups’ (n = 25) ADC values were examined. Further, this study investigated if and how ADC values were related to fibrosis stages and histological activity index (HAI) scores.

Results

The mean ADC value of the liver was smaller in the study group compared with the control group (P < 0.001). Spearman rho correlation analyses showed lower ADC values were associated with higher fibrosis and HAI scores (P < 0.01). There were statistically significant differences in liver ADC values between each combination of fibrosis stages (e.g. stages 0 and 1, 0 and 2) except for stages 1 and 2.

Conclusions

ADC values prove to be a valuable technique for the diagnosis of liver fibrosis and inflammation. They can also be useful in fibrosis staging, particularly in distinguishing later stages of fibrosis from intermediate and early stages.

Key Points

  • Diffusion Weighted MRI is a promising technique for diagnosis of liver fibrosis.
  • Apparent Diffusion Coefficients provide valuable information for staging of liver fibrosis.
  • DWI may offer alternative to biopsy for assessing liver fibrosis.
Literatur
1.
Zurück zum Zitat Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S et al (2004) Reversibility of cirrhosis in autoimmune hepatitis. Am J Med 117:125–129PubMedCrossRef Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S et al (2004) Reversibility of cirrhosis in autoimmune hepatitis. Am J Med 117:125–129PubMedCrossRef
2.
Zurück zum Zitat Wanless IR, Nakashima E, Sherman M (2000) Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124:1599–1607PubMed Wanless IR, Nakashima E, Sherman M (2000) Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124:1599–1607PubMed
3.
Zurück zum Zitat Dufour JF, DeLellis R, Kaplan MM (1998) Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci 43:2573–2576PubMedCrossRef Dufour JF, DeLellis R, Kaplan MM (1998) Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci 43:2573–2576PubMedCrossRef
4.
Zurück zum Zitat Rambaldi A, Gluud C (2005) Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2:CD002148PubMed Rambaldi A, Gluud C (2005) Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2:CD002148PubMed
5.
Zurück zum Zitat Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y (2007) Amelioration of hepatic fibrosis via beta-glucosyl- ceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol 19:1021–1029PubMedCrossRef Safadi R, Zigmond E, Pappo O, Shalev Z, Ilan Y (2007) Amelioration of hepatic fibrosis via beta-glucosyl- ceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution. Int Immunol 19:1021–1029PubMedCrossRef
6.
Zurück zum Zitat Berg T, Sarrazin C, Hinrichsen H et al (2004) Does non-invasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C? Hepatology 39:1456–1457PubMedCrossRef Berg T, Sarrazin C, Hinrichsen H et al (2004) Does non-invasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C? Hepatology 39:1456–1457PubMedCrossRef
7.
Zurück zum Zitat Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160–1174PubMedCrossRef Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160–1174PubMedCrossRef
9.
Zurück zum Zitat Vallet-Pichard A, Mallet V, Nalpas B et al (2007) FIB- 4: an inexpensive and accurate marker of fibrosis in HCV infection—comparison with liver biopsy and FibroTest. Hepatology 46:32–36PubMedCrossRef Vallet-Pichard A, Mallet V, Nalpas B et al (2007) FIB- 4: an inexpensive and accurate marker of fibrosis in HCV infection—comparison with liver biopsy and FibroTest. Hepatology 46:32–36PubMedCrossRef
10.
Zurück zum Zitat Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54PubMedCrossRef Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54PubMedCrossRef
11.
Zurück zum Zitat Rouvire O, Yin M, Dresner MA et al (2006) MR elastography of the liver: preliminary results. Radiology 240:440–448CrossRef Rouvire O, Yin M, Dresner MA et al (2006) MR elastography of the liver: preliminary results. Radiology 240:440–448CrossRef
12.
Zurück zum Zitat Castera L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350PubMedCrossRef Castera L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, FibroTest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350PubMedCrossRef
13.
Zurück zum Zitat Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229:409–414PubMedCrossRef Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229:409–414PubMedCrossRef
14.
Zurück zum Zitat Hagiwara M, Rusinek H, Lee VS et al (2008) Quantification of liver fibrosis in patients with chronic liver disease using 3D perfusion-weighted MR imaging: preliminary experience. Radiology 246:926–934PubMedCrossRef Hagiwara M, Rusinek H, Lee VS et al (2008) Quantification of liver fibrosis in patients with chronic liver disease using 3D perfusion-weighted MR imaging: preliminary experience. Radiology 246:926–934PubMedCrossRef
15.
Zurück zum Zitat Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937–1952PubMedCrossRef Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR (2008) Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 18:1937–1952PubMedCrossRef
16.
Zurück zum Zitat Kele PG, van der Jagt EJ (2010) Diffusion weighted imaging in the liver. World J Gastroenterol 16:1567–1576PubMedCrossRef Kele PG, van der Jagt EJ (2010) Diffusion weighted imaging in the liver. World J Gastroenterol 16:1567–1576PubMedCrossRef
17.
Zurück zum Zitat Muraoka N, Uematsu H, Kimura H et al (2008) Apparent diffusion coefficient in pancreatic cancer: characterisation and histopathological correlations. J Magn Reson Imaging 27:1302–1308PubMedCrossRef Muraoka N, Uematsu H, Kimura H et al (2008) Apparent diffusion coefficient in pancreatic cancer: characterisation and histopathological correlations. J Magn Reson Imaging 27:1302–1308PubMedCrossRef
18.
Zurück zum Zitat Naganawa S, Sato C, Kumada H et al (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15:71–78PubMedCrossRef Naganawa S, Sato C, Kumada H et al (2005) Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15:71–78PubMedCrossRef
19.
Zurück zum Zitat Inci E, Hocaoglu E, Aydin S, Cimilli T (2011) Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Eur J Radiol. doi:10.1016/j.ejrad.2011.02.024 Inci E, Hocaoglu E, Aydin S, Cimilli T (2011) Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Eur J Radiol. doi:10.​1016/​j.​ejrad.​2011.​02.​024
20.
Zurück zum Zitat Inci E, Kilickesmez O, Hocaoglu E, Aydin S, Bayramoglu S, Cimilli T (2011) Utility of diffusion-weighted imaging in the diagnosis of acute appendicitis. Eur Radiol 21:768PubMedCrossRef Inci E, Kilickesmez O, Hocaoglu E, Aydin S, Bayramoglu S, Cimilli T (2011) Utility of diffusion-weighted imaging in the diagnosis of acute appendicitis. Eur Radiol 21:768PubMedCrossRef
21.
Zurück zum Zitat Girometti R, Furlan A, Bazzocchi M et al (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112:394–408PubMedCrossRef Girometti R, Furlan A, Bazzocchi M et al (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112:394–408PubMedCrossRef
22.
Zurück zum Zitat Moteki T, Horikoshi H (2006) Evaluation of hepatic lesions and hepatic parenchyma using diffusion weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 24:637–645PubMedCrossRef Moteki T, Horikoshi H (2006) Evaluation of hepatic lesions and hepatic parenchyma using diffusion weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 24:637–645PubMedCrossRef
23.
Zurück zum Zitat Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M (1997) Focal liver masses: characterisation with diffusion-weighted echo-planar MR imaging. Radiology 204:739–744PubMed Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M (1997) Focal liver masses: characterisation with diffusion-weighted echo-planar MR imaging. Radiology 204:739–744PubMed
24.
Zurück zum Zitat Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T (1998) Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170:397–402PubMed Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T (1998) Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170:397–402PubMed
25.
Zurück zum Zitat Taouli B, Tolia AJ, Losada M et al (2007) Diffusion weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799–806PubMedCrossRef Taouli B, Tolia AJ, Losada M et al (2007) Diffusion weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189:799–806PubMedCrossRef
26.
Zurück zum Zitat Lewin M, Poujol-Robert A, Boelle PY et al (2007) Diffusion- weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665PubMedCrossRef Lewin M, Poujol-Robert A, Boelle PY et al (2007) Diffusion- weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665PubMedCrossRef
27.
Zurück zum Zitat Sandrasegaran K, Akışık FM, Lin C, Tahir B, Rajan J, Saxena R, Aisen AM (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193(6):1556–60PubMedCrossRef Sandrasegaran K, Akışık FM, Lin C, Tahir B, Rajan J, Saxena R, Aisen AM (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193(6):1556–60PubMedCrossRef
28.
Zurück zum Zitat Soylu A, Kılıçkesmez Ö, Poturoğlu Ş, Dolapçıoğlu C, Serez K, Sevindir İ, Yaşar N, Akyıldız M, Kumbasar B (2010) Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. Diagn Interv Radiol 16:204–208PubMed Soylu A, Kılıçkesmez Ö, Poturoğlu Ş, Dolapçıoğlu C, Serez K, Sevindir İ, Yaşar N, Akyıldız M, Kumbasar B (2010) Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. Diagn Interv Radiol 16:204–208PubMed
29.
Zurück zum Zitat Koinuma M, Ohashi I, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22:80–85PubMedCrossRef Koinuma M, Ohashi I, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22:80–85PubMedCrossRef
30.
Zurück zum Zitat Boulanger Y, Amara M, Lepanto L et al (2003) Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 16:132–136PubMedCrossRef Boulanger Y, Amara M, Lepanto L et al (2003) Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 16:132–136PubMedCrossRef
31.
Zurück zum Zitat Knodell RG, Ishak KG, Black WC et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435PubMedCrossRef Knodell RG, Ishak KG, Black WC et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435PubMedCrossRef
Metadaten
Titel
Utility of diffusion-weighted imaging in the evaluation of liver fibrosis
verfasst von
Ayse Ahsen Bakan
Ercan Inci
Selim Bakan
Suut Gokturk
Tan Cimilli
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 3/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2295-z

Weitere Artikel der Ausgabe 3/2012

European Radiology 3/2012 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.